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A ~ri¢i of prot¢inas¢ inhibitors active against prot¢ina:,,.~ of all four major rda.¢s, in¢ludin Shiihly purifh~..d and well<haraeteriud ~2-macroglob- 
ulin, added to the cell culture medium of routine Nearo 2a neuroblastoma e~lla did not interfere with APP secreta.~ activity. We therefore advance 
the hypothesis that APP sccreta~ activity is localized in an intraceUular ¢omlaartmeat. 
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I, INTRODUCTION 
The dementia in Alzheimer's disease is probably a 
consequence of progressive neural loss. particularly in 
the temporal obe of the neocortex, This neural death 
is accompanied by amyloid plaques and neural tangles. 
The main component of the plaques is the amyloid pep- 
tide, a 39--43 amino acid fragment of th~ amyloid pro- 
cursor protein (APP). This peptide is neurotoxio [1.2]. 
Transgenic mice [3,4] over.expressing the complete APP 
develop amyloid deposits [3], but neural ~11 dnath in the 
brains of  these mice was not observed [5]. Therefore the 
strongest evidence for the central role of APP in the 
pathogenesis of Alzheimcr's disease remains the co-seg- 
regation of point mutations in the APP gone with the 
disease in a few families [6--I0]. 
APP is synthesized as an integral membrane protein 
[1 1]. An ill-understood cleavage step separates the inte- 
gral membrane domain from the ~tracellular domain, 
which is then secreted into the medium [11]. Since this 
proteolytic leavage occurs in the amyloid sequence it- 
self [12-14], APP secretion and formation of the amy- 
loid peptide are mutually exclusive pro=sses. Inhibition 
of the cleavage step would allow one to explore possible 
alternative pathways for the metabolism of APP, Prime 
candidates in that regard are ,',l-antichymotrypsin a d 
ot2.maeroglobulin (a2M), both proteinnse inhibitors 
that are present in neural plaques [15,16]. Recently it 
was reported that simple addition ofg2M to the culture 
medium of neural cells inhibits the normal cleavage of 
APP [17]. Moreover, addition of interleukin.6 (IL-6) to 
the c¢11 cultures induced the production of ~2M [17]. 
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The hypothesis was advanced that local production o f  
IL-6 in the brain of Alzheimcr patients would induce 
local production of a2M which then would interfere 
with normal APP metabolism [17,181. Before exploring 
this hypothesis by over-expr~sion of tz2M in the brain 
of transgenic mice, we first attempted to confirm these 
potentially interesting observations in a marine system. 
The r~ults report~ here demonstrate hat none of the 
observations summarized above were confirmed in our 
system. The results are suggestive of an intracellular 
localization of the APP secretase activity. 
2. MATERIAL AND METHODS 
Ncuro 2a neuroblastoma celi~ w~ro btaiflcd from the American 
TyI'~ Culture Collection attd cultured ;n DMFJFI2 (Gib¢o) with 109~ 
FCS, The humtn neuroblaitoma ¢,¢11 line. SK-N-$H ~,aiso from 
ATCC). was cultured in DME/FI2 with 2~, Ultroser (Gibeo). For 
metabolic labelling ¢~pcriments of the Neuro ~ line, 400,000 cells 
were sgeded into a "i"25 flask (Falcon) and after 24 h the medium was 
replaced by DME/FI2 without serum. Aftgr 24 or 4S h of culture in 
~rum.free conditions, which ~sulted in neural differentiation f the 
celts, pul~-IobcllinB was done with 150/~Ci per ml [~JSJmcthionin¢ 
tHEN) in methionil~e-free DME for 20 min. After a chase period 
performed in DMFJFI2, APP was isolated by double-immune precip- 
itation as de~ribed [igl. For the metabolic labelling of SK-N-SH cells, 
i.500.000 ceils were seeded into a T'/5 flalk, cuhured for 48 h in 
DM~FI2 witl~ 10% FCS, 0.S mM dbCAMP (Sigma), IO/JM retinoic 
acid (Janisen Chimica) and 20 ng,'ml NGF-# (Boehringcr). Th¢~¢ 
drul~ have been shown to result in neurodifferentiation of human 
ncuroblastoma ceils [17]. Further processing ofthe ~iis was done as 
for the Neuro ~ cells. 
A polyclonal ntibody a~ainq APP was raised In rabbits by immu. 
nization with a fusion protein from the T7 ~ne lO protein (pGEMEX. 
Promcga) nd the C- terminal part of mouse APP. starting from amino 
acid 321 [20], [L-6 and monoclonai ntibodies (mAb'~) a~inst N- 
CAM and APP were obtained from Boehringer-Mannheim. ¢2M was 
isolated from citrated human plasma by polyethylene glycol 6000 
precipitation, Sul ;~ltration on Uhro=el AcA 34 (LKB) and affinity 
chromatography on Cibacron blue Sepharose (Pharmacia). sdetailed 
previously [21]. A final purification of native ,2M was accomplished 
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Fig. i. Eff~t of prot¢inarm inhiMtors on tim rmcrction of AFP into the 
cuhum n',:dium by N=uro ~ oelLs. Cells were pub¢ labelled for 20 mm 
and chard for 2 h in the presence of(lane 1) no proteinam inhibitor', 
[ (la:te 2} p~pstatin ¢1/trdml) ~nd I~tatin (SO.ug/mi); (Inn= 3} W~tati.n 
(! p~rml); (latle 4) b~tatin ($0 pWml); (L~nc $) ~l.|mtlehymotwpsht 
(50 pg/ml): (lane 6) ~2M (100/tg/ml): (Dane ?) twpsin inhibitor ( l t~ 
/Jg/mlL aprotinin (10 pg/mi) and TLCR (lOOpg/mi): (lane 8~ E~ (tO 
/~g/ml} and leupeptin (i HiI/ml); (Dane 9) iodoa¢¢tamide (200#M): (lan: 
t0) phenantroline (i raM); (lane I i ~ no protcinase inhibitor. All exper- 
iments were done on at least two different o¢cadon~ with freth pro. 
teina~ inhibitor preparations. Medium was collected from the cetl~ 
and double-immune prt¢ipitation was performed with a polyclonal 
anti.APP antibody. Immune pr~ipitat~ wet,. analy'led ott ?% poly- 
aerylnmide gel. Molecular weight marker~ are indicated on the left. 
The spirant inhibition by iodoaeetamidc (Inca 9) is due to ~l} death, 
by hydtophobic interaction chromatography on a TSK Phenyl-SPW 
column (LKB) [211. Other ptoteinase inhibitor1 (~  Fig. l) were ob- 
tain~ from Ctlbioch©m, 5iiprm and Bothrin~r. 
Total RNA wa~ isolated b)' acid guanidinium thioeyanate xtrac- 
tion [22]. Northern blotting was performed using standard protocols. 
After hybridi~lltlon ovemil~ht at 42"C, washes in 0,3~ SSPE. 0,$% 
SDS at 42"C were pcrform~ and autoradiogruphy wa~ carried out 
for 4B h at -'/0*C. 
3. RESULTS 
After 24 h in serum-free medium, almost all Neuro 
2a neuroblastoma cells in the culture flask were differ- 
entiated and had developed ncurites. Addition of NGF- 
p (20 ng/ml) or  dbCAMP (I raM) did not remarkably 
influen~ the time--course of  this process. Retinoic acid 
(I0/zM) proved toxic to the cells. The: drugs were there- 
fore not used in further experiments. Cell extracts of  the 
dilTerentiated cells stained in Western blotting with a 
mAb to N-CAM which confirmed their neural phcno- 
type. 
After metabolic pulse labelling with [~'~S]methionine, 
protein bands of about 120 kDa were immuno-precipi- 
tared with a polyclonai antibody to murine amyloid 
precursor protein. Without chase the protein was asso- 
ciated with the cells, while after 2--4 h of chase most of 
th~ labelled APP proteins wcre present in the culture 
medium (Fiss. I and 2). 
A series of inhibitors of all known classes of pro- 
teinases, including the brond spectrum proteina.~: inhib- 
itor a2M and ~l-antichymutfyp:,;.., were added to the 
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Fig. 2, Effect of,'e2M on APP synthcfis, A pulsc.¢haJ¢ experiment on 
Ncuro 2a ¢¢Iis cultured in ~rum-frce medium for 24 h in the ab , J~  
(lanes 1.-4) or pmrmnce (lanes $-8) of e.2M (I mbtml). Fresh inhibitor 
was added during the pul~ and again during the charm period. Dou. 
hie-immune precipitated APP was applied on a 7% SDS-poly. 
aerylamide gal. (Lan~ 1.2,5,6) Immune precipitation was p~rfoffn¢d 
on cell extracts ( lanes 1.5) or culture medium (~nes 2.6) imm~l~ately 
alter the pul~ with 150 pCPml ['$]methionin¢ for 20 rain, (Lanes 
3,4.7,8) Intmune precipitation was performed after a cha~ of 4 h in 
complete medium: (lanes 3.?)culture mediunz. (lanes 4.t~)cell extraeu. 
Notice the slightly higher mobility of the rmcrcted APP compared to
the ¢ch.associaied APP, We ob~rved no ¢lTcet on the incorporation 
of label in the ceils by cz2M. Total precipitable label in the call extracts 
used in thi~ experiment was 29x10"cpm and 2?xl0"cpm inlanes I and 
5. respectively, and 24x10" epm and 25x10 b epm in lanes 4 and tL 
rcspectivdy. Gels were exposed for different ime period,L to ascertain 
lincarity of the dl~nals. 
culture medium during the chase period. None influ- 
¢nc=d sc~;rction of APP (Fig. I). 
Previous publications [17,18] have suggested that 
g2M inhibits APP secretase activity. Therefore the pos- 
sible effect of a2M was investigated in detail. 
Addition of highly purified g2M front two different 
batches at high concentrations (100/zg/ml and 1,000 
/zg/ml), pre-incubation of the cells for 24 h, and addition 
of fresh -2M to the medium during the pulse and again 
during the chase period, were all without influence on 
the cleavage of APP (Fig. 2). It is therefore clear that 
~t2M does not affect the metabolism of APP in mouse 
Neuro 2a cells under these conditions. We extended our 
observations to a human neuroblastoma cell line, SK- 
N-SH. These cells were cultured for 48 h in medium 
with neurodiffercntiators and supplemented with 100 
/Jg/ml ~2M. They were then pulse labelled for 20 rain 
in the presence of 100/dg/ml freshly added ot2M and 
finally chased in the presence of 500/zg/ml cz2M (Fig. 
3). Double-immune precipitation of APP from the cul- 
ture medium again did not r~vcal any difference in s¢- 
cretasc activity between th~ control and the test sample 
(Fig. 3). 
We further tested the effect of IL-6 (200 U/roll on the 
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l'::il;. 3. Effect of ¢12M on APP secretion in $K-N-$H htmlan neuro- 
bhtstoma cells. A pulse.chase xperin',:nt on SK-N.SH cells was p,:r- 
formed a=~ in Fig. 2. Double-immune precipitation v,-;~ performed on 
the culture supcrnatants after 2 h of chas¢ in the absentee (lane i)  or 
in the preatnc¢ of 0.S m= n;ttiv¢ =2M (lane 2). Under the culture 
conditio=ts used. apparently only the APP form ¢ontaittinR. the Kunitx 
inhibitor domain is syntllc~ixcd in the SR-N-SH ¢¢11 line used. 
induction ofct2M in Ncuro 2a cells, We were unable to 
detect ¢t2M mRNA either in non.stimulated or in IL-6- 
stimulated Neuro 2a cells, cultured in either serum-free 
or in serum,containing medium: APP mRNA was de- 
tected in all experiments (not shown). Mouse liver 
mRNA was used as a positive control for a2M,mRNA 
(Fig. 4). 
4. DISCUSSION 
Since APP is an integral membrane protein, secretion 
must involve a cleavage step separating the integral 
membrane domain from the secreted part of the protein. 
Given the highly conserved primary structure of APP 
in mouse and human (97.6% identity at the amino acid 
level [20]), we expected and also observed similar kinet- 
ics for the secretion of APP in a mouse neural e¢ll line 
relative to human cell lines ([11]. and our observations). 
In this system, however, we did not observe any inter- 
ference of the secretion process by 0¢2M (in concentra- 
tions up to 1 mg/mi). This was confirmed in the human 
ncuroblastoma ¢¢11 line. SK-N-SH, Moreover, co-trans- 
fection of COS cells with mouse at2M and APP also did 
not influence the secretion of  APP (our unpublished 
resultsL It is therefore less likely that differences in the 
c¢11 system used can explain the discrepancies between 
our observations and those previously pub!ishcd [17]. 
Since the ¢2M preparation we used was purified follow- 
ing well-established protocols [21], and has been thor- 
oughly characterized as being the active form of ~2M. 
we suggest hat the inhibitory effect of the o:2M ob- 
served by Gantcr et al, [17] could have been caused by 
other substances in the preparation of ¢¢2M. "l"his would 
explain the fact that very high concentrations were 
needed to observe the effect on APP processing. It re- 
mains to be seen whether the addition of that prepara- 
tion, which also diminished the total incorporation of 
['~JS]methionin¢ (see the legend to Fig. 3 in [17]), would 
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Fig. 4. Northern blot of total RNA cxtntct, with an ¢2M-spccifie 
prot'<. Neuro ~ cells were cultured in serum.free medium for .,34 h in 
tile ab~cn¢c (lane I) or prc'~:nc¢ of 200 U/m| inlerleukin 6 throe 2), 
(Lane el) Mou~ liver RNA. In ~:wr~ lane 10/~ll total mRNA was 
applied. The probe w;t.= a :L t kbcDNA .E'.¢,R t fnL~m¢cl of~ou~e ¢=2M 
¢V:m Leuvcn. unpublished result). Markers arc indic~ttcd on the left. 
have other effects on the coils unrelated to the pro- 
tcinas¢ inhibitor capacity of a21Vt. The induction of 
e,2M in neural cells by IL-6 was previously investigated 
at the protein level using a polyclonal ¢2M antiserum 
[17]. We were not able to detect mouse ¢2M mRNA. 
which is at more sensitive :tad specific .ass:ty. The hy- 
pothesis that IL-6 would induce synthesis of a2M in 
neural cells, and thereby would interfere with the nor. 
raal metabolism of APP [16.18]. is thus not consistently 
confirmed ha all ¢xperimental systems, 
As well as o:2M, inhibitors of  all major classes of 
proteinases, including ,',l-antichymot,'ypsin which is :t 
specific marker for tile plaques in Alzheimer's disease 
[15], also had no effect on the cleavage of APP, A pos- 
sible i,~terpretation f these data is that the hypothetical 
APP secrera,,i¢ isa highly specific proteinase with which 
none of the tested proteinase inhibitors interact. On the 
other hand, however, major structural alterations of 
APP at the cleavage site [23] do not aiter its secretion 
into the medium, which suggests that the specificity of 
APP secr=tase is relatively low, We advance, tl~ereforc, 
the alternative possibility that the secretas= activity is 
localized intraccllularly and that the protcinase inhib- 
itors added to th,: culture medium do not attain the 
secreta~e under the experimental conditions used, 
Cathepsin B, a lysosomal proteinase, i~as b==n ad- 
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v=n¢¢d as a possible APP s¢cretus¢ based on i¢s activity 
on synthetic pepzides mimicking the ¢leavuge size in 
APP [24,], Others [25.26]. however, found no effect ot" 
lysosomal proteinas¢ inhibito-s on APP secretas¢ ~cdv- 
ity. Although our results do r, ot contradict the possibil- 
ity of lysosoma| processing oi" APP. oth~r cellular com- 
partments (e.g, endosomes. Golgi-appar-tus) remain 
possible .'ts well, 
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